Point72 Asia (Singapore)’s Kyverna Therapeutics KYTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$37K	Buy	+12,039	New	+$37K	0.01%	649
2024 Q2	–	Sell	-10,133	Closed	-$252K	–	1567
2024 Q1	$252K	Buy	+10,133	New	+$252K	0.07%	342